These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25327515)

  • 41. Is health promotion the starting point of primary cardiovascular care in low- and middle-income countries like Nepal?
    Vaidya A; Krettek A
    Health Promot Pract; 2012 May; 13(3):412-5. PubMed ID: 22447668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and cardiovascular disease in developing countries: a growing problem and an economic threat.
    Raymond SU; Leeder S; Greenberg HM
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):111-6. PubMed ID: 16477174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The double burden of communicable and non-communicable diseases in developing countries.
    Boutayeb A
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):191-9. PubMed ID: 16274715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global health agenda on non-communicable diseases: has WHO set a smart goal for physical activity?
    de Souto Barreto P
    BMJ; 2015 Jan; 350():h23. PubMed ID: 25608835
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of cardiovascular diseases: a spearhead for control of noncommunicable diseases.
    Puska P
    East Mediterr Health J; 2014 Jul; 20(7):407-8. PubMed ID: 25023766
    [No Abstract]   [Full Text] [Related]  

  • 46. The World Heart Federation's vision for worldwide cardiovascular disease prevention.
    Yusuf S; Wood D; Ralston J; Reddy KS
    Lancet; 2015 Jul; 386(9991):399-402. PubMed ID: 25892680
    [No Abstract]   [Full Text] [Related]  

  • 47. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention.
    Kraushaar LE; Krämer A
    BMC Public Health; 2009 Feb; 9():64. PubMed ID: 19232132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stemming the global tsunami of cardiovascular disease.
    Anand SS; Yusuf S
    Lancet; 2011 Feb; 377(9765):529-32. PubMed ID: 21295845
    [No Abstract]   [Full Text] [Related]  

  • 49. Global cardiovascular disease prevention: time to get serious.
    Beaglehole R
    Lancet; 2001 Aug; 358(9282):661-3. PubMed ID: 11530175
    [No Abstract]   [Full Text] [Related]  

  • 50. Global burden of cardiovascular disease and stroke: hypertension at the core.
    Lackland DT; Weber MA
    Can J Cardiol; 2015 May; 31(5):569-71. PubMed ID: 25795106
    [No Abstract]   [Full Text] [Related]  

  • 51. An epidemic of risk factors for cardiovascular disease.
    Lancet; 2011 Feb; 377(9765):527. PubMed ID: 21315931
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiovascular disease research and the development agenda in low- and middle-income countries.
    Burroughs Pena MS; Bloomfield GS
    Glob Heart; 2015 Mar; 10(1):71-3. PubMed ID: 25754569
    [No Abstract]   [Full Text] [Related]  

  • 53. The Missouri Cardiovascular Health Plan: a focus on prevention.
    Dabney S; Smith C; Brownson R; Goldberg A; LaFontaine T
    Mo Med; 1992 Jun; 89(6):362-6. PubMed ID: 1320184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the global cardiovascular disease taskforce.
    Smith SC; Chen D; Collins A; Harold JG; Jessup M; Josephson S; Logstrup S; Jur C; Sacco RL; Vardas PE; Wood DA; Zoghbi WA
    Circulation; 2013 Dec; 128(23):2546-8. PubMed ID: 24045045
    [No Abstract]   [Full Text] [Related]  

  • 55. Heart on the hill 2002.
    Collins-Nakai RL
    Can J Cardiol; 2002 Jan; 18(1):17-20. PubMed ID: 11826323
    [No Abstract]   [Full Text] [Related]  

  • 56. Global Perspectives On Pediatric Cardiac Critical Care.
    Penny DJ
    Pediatr Crit Care Med; 2016 Aug; 17(8 Suppl 1):S388-93. PubMed ID: 27490628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results.
    Fuster V
    J Am Coll Cardiol; 2014 Aug; 64(5):520-2. PubMed ID: 25082587
    [No Abstract]   [Full Text] [Related]  

  • 58. Health promotion applied to infectious diseases.
    McQueen DV
    Glob Health Promot; 2015 Jun; 22(2):3-4. PubMed ID: 26034139
    [No Abstract]   [Full Text] [Related]  

  • 59. The modifiable burden of worldwide mortality from cardiovascular diseases.
    Huxley RR; Perkovic V
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):604-6. PubMed ID: 24842600
    [No Abstract]   [Full Text] [Related]  

  • 60. CardioPulse: Prevention of global cardiovascular disease.
    Yusuf S; Wood D; Ralston J; Reddy KS
    Eur Heart J; 2016 Feb; 37(6):505-7. PubMed ID: 27458620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.